René Russo
2022 - Xilio Therapeutics
In 2022, René Russo earned a total compensation of $2.2M as Chief Executive Officer at Xilio Therapeutics, a 60% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $306,763 |
|---|---|
| Option Awards | $1,323,615 |
| Salary | $575,000 |
| Other | $6,730 |
| Total | $2,212,108 |
Russo received $1.3M in option awards, accounting for 60% of the total pay in 2022.
Russo also received $306.8K in non-equity incentive plan, $575K in salary and $6.7K in other compensation.
Rankings
In 2022, René Russo's compensation ranked 1,615th out of 5,625 executives tracked by ExecPay. In other words, Russo earned more than 71.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,615 out of 5,625 | 71st |
Division Manufacturing | 826 out of 3,053 | 73rd |
Major group Chemicals And Allied Products | 321 out of 1,380 | 77th |
Industry group Drugs | 297 out of 1,281 | 77th |
Industry Pharmaceutical Preparations | 213 out of 927 | 77th |
Source: SEC filing on April 25, 2023.
Russo's colleagues
We found two more compensation records of executives who worked with René Russo at Xilio Therapeutics in 2022.